Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,719 public trials 1,764 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NCT06293898

Conditions
Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +51 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Los Angeles, California, United States
  • Scripps Health San Diego, California, United States
View all 17 locations
View Trial Details
Recruiting

PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer

NCT04360941

Conditions
Breast Diseases, Breast Neoplasms, ER+ Breast Cancer, +10 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • Addenbrooke's Hospital Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Hope Clinical Trials Cancer Centre Leicester, United Kingdom
View Trial Details
Recruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

NCT05592938

Conditions
Breast Cancer, Breast Cancer Recurrent, Breast Diseases, +5 more
Locations
  • NYU Langone Health New York, United States
  • Columbia University Medical Center New York, United States
  • Virgina Community University Massey Comprehensive Cancer Center Richmond, Virginia, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
View all 19 locations
View Trial Details
Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

NCT07173751

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University Of California - San Diego Moores Cancer Center La Jolla, California, United States
  • Cedar Sinai - Samuel Oschin Cancer Center Los Angeles, California, United States
  • Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto, California, United States
View all 155 locations
View Trial Details
Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

NCT07287098

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Hematology/Oncology - Parkside Santa Monica, California, United States
View all 78 locations
View Trial Details
Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +29 more
Locations
  • Yale University - Yale University School of Medicine New Haven, Connecticut, United States
  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Huntersville, North Carolina, United States
  • NEXT Houston Galveston, Texas, United States
  • NEXT Oncology - PARENT San Antonio, Texas, United States
View Trial Details

Related conditions